← Open Payments lookup

MICHELLE TRAN: Open Payments

NPI 1184393217 · SILVER SPRING, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$381 in 19 payments from 10 companies in 2025. Trend: 2023 $581 · 2024 $1,357 · 2025 $381

Food & beverage: $381
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP4$89
Amgen Inc.3$67
ABBVIE INC.3$67
Novo Nordisk Inc3$49
Seqirus USA Inc1$20
GlaxoSmithKline, LLC.1$19
PFIZER INC.1$19
Abbott Laboratories1$19
Astellas Pharma US Inc1$17
Cranial Technologies, Inc1$14

Products named: OTEZLA, AIRSUPRA, UBRELVY, QULIPTA, Ozempic, FARXIGA, Fluad, BEXSERO.

Industry payments across MD — which companies pay providers there.